NM_004285.4:c.2019T>C
Variant names:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_004285.4(H6PD):c.2019T>C(p.Tyr673Tyr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.399 in 1,612,808 control chromosomes in the GnomAD database, including 130,814 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.42 ( 13577 hom., cov: 33)
Exomes 𝑓: 0.40 ( 117237 hom. )
Consequence
H6PD
NM_004285.4 synonymous
NM_004285.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -3.55
Genes affected
H6PD (HGNC:4795): (hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase) There are 2 forms of glucose-6-phosphate dehydrogenase. G form is X-linked and H form, encoded by this gene, is autosomally linked. This H form shows activity with other hexose-6-phosphates, especially galactose-6-phosphate, whereas the G form is specific for glucose-6-phosphate. Both forms are present in most tissues, but H form is not found in red cells. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BP6
Variant 1-9264512-T-C is Benign according to our data. Variant chr1-9264512-T-C is described in ClinVar as [Benign]. Clinvar id is 1540015.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-9264512-T-C is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-3.55 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.483 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
H6PD | ENST00000377403.7 | c.2019T>C | p.Tyr673Tyr | synonymous_variant | Exon 5 of 5 | 1 | NM_004285.4 | ENSP00000366620.2 | ||
H6PD | ENST00000602477.1 | c.2052T>C | p.Tyr684Tyr | synonymous_variant | Exon 5 of 5 | 1 | ENSP00000473348.1 |
Frequencies
GnomAD3 genomes AF: 0.418 AC: 63544AN: 151990Hom.: 13564 Cov.: 33
GnomAD3 genomes
AF:
AC:
63544
AN:
151990
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.412 AC: 102994AN: 250056Hom.: 22379 AF XY: 0.413 AC XY: 55947AN XY: 135554
GnomAD3 exomes
AF:
AC:
102994
AN:
250056
Hom.:
AF XY:
AC XY:
55947
AN XY:
135554
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.397 AC: 579938AN: 1460700Hom.: 117237 Cov.: 46 AF XY: 0.400 AC XY: 290567AN XY: 726670
GnomAD4 exome
AF:
AC:
579938
AN:
1460700
Hom.:
Cov.:
46
AF XY:
AC XY:
290567
AN XY:
726670
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.418 AC: 63590AN: 152108Hom.: 13577 Cov.: 33 AF XY: 0.417 AC XY: 31040AN XY: 74356
GnomAD4 genome
AF:
AC:
63590
AN:
152108
Hom.:
Cov.:
33
AF XY:
AC XY:
31040
AN XY:
74356
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1164
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided
- -
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Cortisone reductase deficiency 1 Benign:1
Apr 11, 2023
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at